AbCellera Biologics Inc. (ABCL) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Company Overview - AbCellera has been on a 13-year journey focused on technology investments in drug discovery, transitioning from target nomination to manufacturing drug products for antibody-based therapeutics [2] Technological Differentiation - The company emphasizes its technological differentiation in drug discovery, which has been a key factor in its progress and success in over 100 drug discovery programs [2]